Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
Details for Australian Patent Application No. 2010265964 (hide)
International Classifications
Event Publications
2 February 2012 PCT application entered the National Phase
PCT publication WO2010/151823 Priority application(s): WO2010/151823
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010265971-Heterocyclic compounds and their uses as inhibitors of PI3 K activity
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser